EPISODE · Jul 28, 2022 · 47 MIN
An Intersectional Look at Anal Cancer and HIV
from HealthCast · host GovCIO Media & Research
In June, a study supported by the National Cancer Institute found that for people with HIV, early treatment of precancerous anal lesions caused by human papillomavirus (HPV) can cut rates of anal cancer incidence by more than half. These findings from the Anal Cancer/HSIL Outcomes Research (ANCHOR) study are creating secondary prevention options for those at risk for anal cancer who have not received the HPV vaccine. We look into the history of the study and what its work means for those at risk for anal cancer.
NOW PLAYING
An Intersectional Look at Anal Cancer and HIV
No transcript for this episode yet
Similar Episodes
Jun 25, 2026 ·8m
Jun 25, 2026 ·29m
Jun 25, 2026 ·19m
Jun 25, 2026 ·28m
Jun 25, 2026 ·13m
Jun 25, 2026 ·13m